A trial of 9-ING-41 in children and adolescents with neuroblastoma
Latest Information Update: 22 Nov 2019
At a glance
- Drugs Elraglusib (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- Sponsors Actuate Therapeutics
- 22 Nov 2019 New trial record
- 12 Nov 2019 According to an Actuate Therapeutics media release, the company expects to initiate this trial in early 2020.